Microbiome signatures can predict nonalcoholic fatty liver disease with high accuracy

Nonalcoholic fatty liver disease (NAFLD) affects up to 40% of the population in western countries and is one of the most common metabolic diseases worldwide. It is characterized by an excessive storage of fat in the liver cells, which can lead to an approximately 10% increase in liver weight with reduced liver function.

Leave A Comment

Your email address will not be published. Required fields are marked *